| 05/20/2026 3:15 PM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 4:45 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 4:50 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:15 PM | Gilead Sciences (882095) Filer | Form 424B5 | |
| 05/14/2026 4:11 PM | Gilead Sciences (882095) Subject | Form FWP | |
| 05/14/2026 7:46 AM | Gilead Sciences (882095) Filer | Form 424B5 | |
| 05/08/2026 4:00 PM | Gilead Sciences (882095) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 05/07/2026 4:12 PM | Gilead Sciences (882095) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/07/2026 4:13 PM | Gilead Sciences (882095) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/07/2026 3:03 PM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/04/2026 3:31 PM | Gilead Sciences (882095) Issuer Horning Sandra (1638709) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for GILD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/04/2026 3:36 PM | BARTON JACQUELINE K (1183680) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:19 PM | Gilead Sciences (882095) Issuer Kramer Kelly A. (1629885) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:20 PM | Gilead Sciences (882095) Issuer MANWANI HARISH (1527726) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 3:05 PM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 5:41 PM | Gilead Sciences (882095) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 4:53 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/28/2026 8:13 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SCHEDULE 13D/A | |
| 04/28/2026 7:53 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-T/A | |
| 04/28/2026 7:56 AM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 8:00 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-T/A | |
| 04/16/2026 5:40 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 5:41 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 3:12 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/15/2026 3:08 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/01/2026 3:34 PM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-T/A | |
| 03/30/2026 4:59 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 3:03 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/26/2026 5:40 PM | Gilead Sciences (882095) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/17/2026 5:56 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 5:14 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/12/2026 3:45 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/12/2026 3:24 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:46 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 1:49 PM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-C | |
| 02/23/2026 5:46 AM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 5:48 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SC TO-C | |
| 02/23/2026 5:51 AM | Arcellx, Inc. (1786205) Subject Gilead Sciences (882095) Filed by | Form SCHEDULE 13D | |
| 02/18/2026 4:11 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 4:31 PM | Gilead Sciences (882095) Reporting Xilio Therapeutics, Inc. (1840233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 6:26 PM | Cain Wettan Keeley M (2110603) Reporting Gilead Sciences (882095) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad) When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days.
One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker. See the stock Musk's own words pointed to right here |
| 02/06/2026 3:22 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:49 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:51 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 5:46 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 12:23 PM | FMR LLC (315066) Filed by Gilead Sciences (882095) Subject | Form SCHEDULE 13G | |
| 01/29/2026 4:23 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 6:29 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 3:03 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/22/2026 3:32 PM | Gilead Sciences (882095) Subject Telman Deborah H (1860008) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/21/2026 3:26 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 3:01 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/16/2026 5:10 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/16/2026 5:18 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 3:01 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/15/2026 3:02 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/05/2026 4:56 PM | Berger Dietmar (1739515) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/30/2025 3:23 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 5:31 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 5:12 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 3:04 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 3:04 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/11/2025 7:38 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 7:40 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/11/2025 5:25 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/01/2025 5:11 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/01/2025 3:36 PM | Gilead Sciences (882095) Reporting Xilio Therapeutics, Inc. (1840233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/28/2025 12:02 PM | Bluestone Jeffrey (1771814) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/28/2025 12:05 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/26/2025 3:16 PM | Gilead Sciences (882095) Subject Kramer Kelly A. (1629885) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/19/2025 7:30 AM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/18/2025 6:00 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 5:51 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 3:05 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/17/2025 3:06 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/13/2025 6:36 PM | Gilead Sciences (882095) Issuer Telman Deborah H (1860008) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 4:07 PM | Gilead Sciences (882095) Subject Wilfong Diane E. (1374988) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/13/2025 3:44 PM | Gilead Sciences (882095) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 11/05/2025 4:19 PM | Arcus Biosciences, Inc. (1724521) Subject Gilead Sciences (882095) Filed by | Form SCHEDULE 13D/A | |
| 10/29/2025 3:14 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/28/2025 4:47 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/27/2025 6:43 PM | Gilead Sciences (882095) Issuer Telman Deborah H (1860008) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/16/2025 8:35 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/16/2025 8:28 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/15/2025 3:03 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/15/2025 3:05 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/06/2025 7:17 AM | Gilead Sciences (882095) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/03/2025 3:30 PM | ASSEMBLY BIOSCIENCES, INC. (1426800) Issuer Gilead Sciences (882095) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/30/2025 3:57 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/29/2025 3:09 PM | Gilead Sciences (882095) Subject O'Day Daniel Patrick (1638643) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/23/2025 6:53 PM | Burkhart Erin (1927648) Reporting Gilead Sciences (882095) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Musk's shopping list: batteries ✓ solar ✓ data ✓ power ___ (Ad) Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity for $2.6 billion and Twitter for $44 billion. Now one small company makes the equipment his Colossus supercomputer - a million GPUs consuming nearly $1 billion a month in power - cannot run without.
Analyst Dylan Jovine has identified the name and ticker. For investors who own shares before a potential move, the math could be significant. See the stock Musk's acquisition pattern points to next |
| 09/23/2025 6:55 PM | Burkhart Erin (1927648) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2025 4:12 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2025 4:16 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2025 3:38 PM | Dickinson Andrew D (1310204) Reporting Gilead Sciences (882095) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/15/2025 3:04 PM | Gilead Sciences (882095) Subject Mercier Johanna (1782135) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/11/2025 6:31 PM | Gilead Sciences (882095) Issuer Telman Deborah H (1860008) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2025 6:34 PM | Gilead Sciences (882095) Issuer Wilfong Diane E. (1374988) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2025 6:38 PM | Gilead Sciences (882095) Issuer O'Day Daniel Patrick (1638643) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2025 5:31 PM | Gilead Sciences (882095) Issuer Mercier Johanna (1782135) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |